SLE brain disease is a dubious disease in the field of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathology testing.
The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individual development of treatment programs for treatment and management of SLE brain disease typically includes pharmacotherapy, rehabilitation prevention, and regular follow-up. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many neurological disorders that have previously been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely schemes according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of SLE brain disease. The platform serves a team of domestic and foreign experts in the field of neural systems aligned with the China International Medical Service System, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.